BWC
BSX icon

Blue Whale Capital’s Boston Scientific BSX Stock Holding History

Blue Whale Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,062,458
Closed -$38.2M – 19
2020
Q4 		$38.2M Buy
1,062,458
+191,800
+22% +$6.91M 5.44% 10
2020
Q3 		$33.3M Buy
870,658
+230,458
+36% +$8.88M 6.43% 8
2020
Q2 		$22.5M Buy
640,200
+161,000
+34% +$5.8M 6.07% 9
2020
Q1 		$15.6M Buy
479,200
+166,500
+53% +$6.5M 6.9% 5
2019
Q4 		$14.1M Buy
+312,700
New +$13.1M 7.09% 7

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Blue Whale Capital's BSX Position: Q1 2021 in Review

Blue Whale Capital sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 1,062,458 shares — an estimated $38.2M sold.

Blue Whale Capital first reported a position in BSX in Q4 2019 and held it in 5 quarters. The position peaked at $38.2M in Q4 2020. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Blue Whale Capital reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Blue Whale Capital sold 1,062,458 Boston Scientific shares in Q1 2021, an estimated $38.2M.
  • Blue Whale Capital first reported a position in Boston Scientific in Q4 2019 and held it in 5 quarters.
  • Blue Whale Capital's Boston Scientific position peaked at $38.2M in Q4 2020.
  • 830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Blue Whale Capital's 13F filing for Q1 2021, filed 14 May 2021.